4//SEC Filing
Jones Mitchell Lawrence 4
Accession 0001493152-24-018284
CIK 0001357459other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 6:37 PM ET
Size
15.8 KB
Accession
0001493152-24-018284
Insider Transaction Report
Form 4
Jones Mitchell Lawrence
Chief Medical Officer
Transactions
- Tax Payment
Common Stock, par value $0.01
2024-05-06$8.46/sh−90$761→ 724 total - Exercise/Conversion
Common Stock, par value $0.01
2024-05-06+156→ 880 total - Exercise/Conversion
Restricted Stock Units
2024-05-06−304→ 2,735 total→ Common Stock (304 underlying) - Exercise/Conversion
Restricted Stock Units
2024-05-06−156→ 1,555 total→ Common Stock (156 underlying) - Exercise/Conversion
Common Stock, par value $0.01
2024-05-06+304→ 814 total - Tax Payment
Common Stock, par value $0.01
2024-05-06$8.46/sh−47$398→ 833 total
Footnotes (7)
- [F1]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023.
- [F2]Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.
- [F3]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.
- [F4]Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.
- [F5]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F6]This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.
- [F7]This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001993292
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 6:37 PM ET
- Size
- 15.8 KB